Standard
A New Wave of ADHD Medications Prompts the Question: Should You Switch?
For nearly two decades, the landscape of Attention-Deficit/Hyperactivity Disorder (ADHD) treatment felt largely static, defined by a familiar rotation of tried-and-true molecules packaged into new delivery systems. Clinicians and patients worked within a well-worn pharmaceutical toolkit, leaning primarily on established stimulants and a small handful of non-stimulant alternatives. However, the past five years have disrupted…
